LB PHARMACEUTICALS INC (LBRX) Executive Compensation
LB PHARMACEUTICALS INC (LBRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LBRX
CIK: 1691082
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerJoseph Scheriff
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-13 | 2026-10-09 | 4 Filing | 0001746372-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-09 | 4 Filing | 0002150267-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-13 | — | SCHEDULE 13G/A Filing | 0000019617-26-000360 | View SEC Doc Filr Page |
| EFFECT | 2026-10-05 | — | EFFECT Filing | 9999999995-26-003150 | View SEC Doc Filr Page |
| POS AM | 2026-10-01 | — | POS AM | 0001193125-26-410664 | View SEC Doc Filr Page |
| S-3ASR | 2026-10-01 | — | S-3ASR | 0001193125-26-410651 | View SEC Doc Filr Page |
| 3 | 2026-09-24 | 2026-09-14 | 3 Filing | 0002150267-26-000003 | View SEC Doc Filr Page |
| 424B3 | 2026-09-15 | — | 424B3 | 0001193125-26-391384 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001193125-26-391358 | View SEC Doc Filr Page |
| 3 | 2026-09-14 | 2026-09-02 | 3 Filing | 0001746372-26-000005 | View SEC Doc Filr Page |
| 424B3 | 2026-09-03 | — | 424B3 | 0001193125-26-381100 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | 8-K | 0001193125-26-381076 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352336 | View SEC Doc Filr Page |
| 424B3 | 2026-08-11 | — | 424B3 | 0001193125-26-343542 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343490 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343479 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001193125-26-331058 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0002012383-26-002809 | View SEC Doc Filr Page |
| 424B3 | 2026-07-29 | — | 424B3 | 0001193125-26-322276 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-28 | 8-K | 0001193125-26-322208 | View SEC Doc Filr Page |
| 424B3 | 2026-07-22 | — | 424B3 | 0001193125-26-311394 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-22 | 8-K | 0001193125-26-311357 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-16 | — | SCHEDULE 13G Filing | 0000019617-26-000264 | View SEC Doc Filr Page |
| 424B3 | 2026-06-10 | — | 424B3 | 0001193125-26-266020 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-08 | 8-K | 0001193125-26-265867 | View SEC Doc Filr Page |